Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L R Brunet

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Advances in Experimental Medicine and Biology|January 16, 1999
The initiation and function of Th2 responses during infection with Schistosoma mansoniE J Pearce, A La Flamme, E Sabin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999
Nitric oxide and the Th2 response combine to prevent severe hepatic damage during Schistosoma mansoni infectionL R Brunet, M Beall, D W Dunne, et al.
Bulletin of the World Health Organization|November 6, 2001
Risk of Lyme disease: perceptions of residents of a Lone Star tick-infested communityP M Armstrong, L R Brunet, A Spielman, et al.
Experimental Parasitology|November 1, 1996
IL-4 in schistosomiasisE J Pearce, J P Vasconcelos, L R Brunet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1997
IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasisL R Brunet, F D Finkelman, A W Cheever, et al.
The Journal of Experimental Medicine|January 1, 1996
Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccineA M de Silva, S R Telford, L R Brunet, et al.
Infection and Immunity|May 25, 1999
Interleukin 5 (IL-5) is not required for expression of a Th2 response or host resistance mechanisms during murine schistosomiasis mansoni but does play a role in development of IL-4-producing non-T, non-B cellsL R Brunet, E A Sabin, A W Cheever, et al.
The Journal of Experimental Medicine|August 1, 1993
Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccinesS R Telford, E Fikrig, S W Barthold, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1995
Borrelia burgdorferi infection is rarely found in patients with chronic fatigue syndromeR J Pollark, A L Komaroff, S R Telford, et al.
Infection and Immunity|December 19, 2000
Severe schistosomiasis in the absence of interleukin-4 (IL-4) is IL-12 independentE A Patton, L R Brunet, A C La Flamme, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Advances in Experimental Medicine and Biology|January 16, 1999
The initiation and function of Th2 responses during infection with Schistosoma mansoniE J Pearce, A La Flamme, E Sabin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999
Nitric oxide and the Th2 response combine to prevent severe hepatic damage during Schistosoma mansoni infectionL R Brunet, M Beall, D W Dunne, et al.
Bulletin of the World Health Organization|November 6, 2001
Risk of Lyme disease: perceptions of residents of a Lone Star tick-infested communityP M Armstrong, L R Brunet, A Spielman, et al.
Experimental Parasitology|November 1, 1996
IL-4 in schistosomiasisE J Pearce, J P Vasconcelos, L R Brunet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1997
IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasisL R Brunet, F D Finkelman, A W Cheever, et al.
The Journal of Experimental Medicine|January 1, 1996
Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccineA M de Silva, S R Telford, L R Brunet, et al.
Infection and Immunity|May 25, 1999
Interleukin 5 (IL-5) is not required for expression of a Th2 response or host resistance mechanisms during murine schistosomiasis mansoni but does play a role in development of IL-4-producing non-T, non-B cellsL R Brunet, E A Sabin, A W Cheever, et al.
The Journal of Experimental Medicine|August 1, 1993
Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccinesS R Telford, E Fikrig, S W Barthold, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1995
Borrelia burgdorferi infection is rarely found in patients with chronic fatigue syndromeR J Pollark, A L Komaroff, S R Telford, et al.
Infection and Immunity|December 19, 2000
Severe schistosomiasis in the absence of interleukin-4 (IL-4) is IL-12 independentE A Patton, L R Brunet, A C La Flamme, et al.
Pageof 3